fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Advertisment

Change concept of harm reduction in alcohol policy

Written by | 8 Jan 2014 | All Medical News

A new policy paper by a University of York academic calls for limits on the influence of the drinks industry in shaping alcohol policy because it has a ‘fundamental conflict of interest’.

It says the concept of harm reduction has been co-opted by industry interests in public health debates about reducing the damage caused by alcohol. The paper argues for a redefinition of the concept of alcohol harm reduction to include the full range of evidence-based measures that reduce alcohol damage to public health and society.

Professor McCambridge and colleagues say the concept of harm reduction has been important in advancing science, policy and practice for illicit drug use, particularly as a vehicle for more enlightened responses to injecting drug use and HIV.

They point out that the drinks industry favours a policy of reducing harm by means other than people cutting their alcohol consumption – an approach that is unlikely to meet its stated objective.

Professor McCambridge said: “The ability of the alcohol industry to shape alcohol policy nationally and globally needs to be curtailed because of a fundamental conflict of interest with reducing alcohol harms.”

The paper states that a “simplistic transfer of definitions of harm reduction from drugs to alcohol weakens society’s ability to reduce the scale of the alcohol problem and protect public health. It is thus important to expose the limitations of the alcohol industry-favoured definition. Instead we offer a simpler definition of harm reduction which gets to the heart of the matter. Put simply, if a policy or programme reduces harms or problems, then it is harm reduction.”

The article by Professor Jim McCambridge, of the Department of Health Sciences at York and academics at King’s College London and the University of Newcastle, New South Wales, is published in this week’s PLOS Medicine.

 

Contact: David Garner
david.garner@york.ac.uk

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.